Hims & Hers launches weight-loss and men's health treatments in Australia

Telehealth company Hims & Hers has begun offering branded GLP-1 weight-loss drugs and various other treatments to men in Australia. This expansion follows the company's acquisition of the Australian digital health platform Eucalyptus earlier this year.

Through the acquisition of the Sydney-based men’s telehealth brand Pilot, Hims & Hers will provide products ranging from sexual health medications to cholesterol treatments. The company also plans to launch a women’s health segment in Australia later this year via Juniper, Eucalyptus’ women’s brand.

Tim Doyle, former Eucalyptus CEO and current senior vice president at Hims & Hers, stated that the move aims to provide more comprehensive weight-loss care and improve access for Australians, particularly those in rural areas facing travel and wait time challenges. Hims & Hers has set a revenue target of $6.5 billion by 2030 and continues to invest in international expansion, diagnostic testing, and manufacturing infrastructure.